Source: BEFREE

Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 5291
Gene Symbol: PIK3CB
PIK3CB
CUI: C4721661
Disease: Stage IV Lung Squamous Cell Carcinoma AJCC v7
Stage IV Lung Squamous Cell Carcinoma AJCC v7 		0.010 GeneticVariation BEFREE SWOG S1400B (NCT02785913), a Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study). 31158500

2019
Entrez Id: 5290
Gene Symbol: PIK3CA
PIK3CA
CUI: C4721661
Disease: Stage IV Lung Squamous Cell Carcinoma AJCC v7
Stage IV Lung Squamous Cell Carcinoma AJCC v7 		0.010 GeneticVariation BEFREE SWOG S1400B (NCT02785913), a Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study). 31158500

2019
Entrez Id: 5293
Gene Symbol: PIK3CD
PIK3CD
CUI: C4721661
Disease: Stage IV Lung Squamous Cell Carcinoma AJCC v7
Stage IV Lung Squamous Cell Carcinoma AJCC v7 		0.010 GeneticVariation BEFREE SWOG S1400B (NCT02785913), a Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study). 31158500

2019
Entrez Id: 5294
Gene Symbol: PIK3CG
PIK3CG
CUI: C4721661
Disease: Stage IV Lung Squamous Cell Carcinoma AJCC v7
Stage IV Lung Squamous Cell Carcinoma AJCC v7 		0.010 GeneticVariation BEFREE SWOG S1400B (NCT02785913), a Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study). 31158500

2019